Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-11-21Clinical Trial Update: Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of HS110 vaccine in combination with Erlotinib for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-11Clinical Trial Update: TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV [Phase 2]
A Phase 2 trial evaluating TS-stratified chemotherapy with VEGF inhibition for stage IV non-squamous non-small cell lung cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2013-09-02Clinical Trial Update: QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC [Phase 2]
This is a Phase 2 trial update indicating withdrawal of a study evaluating QOL-Stereotactic Radiosurgery with temozolomide and erlotinib for…
-
CLINICAL_TRIALS withdrawal · 2013-07-25Clinical Trial Update: A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation [Phase 1, Phase 2]
A Phase I/II trial of tivozanib and erlotinib for metastatic non-small cell lung cancer, assigned by VeriStrat serum proteomic evaluation, h…
-
CLINICAL_TRIALS withdrawal · 2013-07-23Clinical Trial Update: 64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab [NA]
The clinical trial evaluating 64CuATSM and hypoxia in stage IV non-small cell lung cancer using carboplatin, paclitaxel, and bevacizumab has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for stage IIIB, stage IV, or recurrent non-small cell lung cancer has been withdrawn fro…
-
CLINICAL_TRIALS withdrawal · 2013-05-29Clinical Trial Update: Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients [Phase 2]
Phase 2 trial of trastuzumab in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-05-10Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating chemotherapy and radiation therapy with or without Efaproxiral for stage III non-small cell lung cancer has been …
-
CLINICAL_TRIALS withdrawal · 2013-04-16Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating gefitinib with radiation therapy for patients with inoperable stage I or II non-small cell lung cancer…
-
CLINICAL_TRIALS withdrawal · 2013-03-26Clinical Trial Update: A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 window-of-opportunity trial of Afatinib in early-stage non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-25Clinical Trial Update: A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating crizotinib in East Asian patients with ALK-positive advanced non-small cell lung cancer has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2013-01-29Clinical Trial Update: Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A phase 3 trial evaluating maintenance IRESSA (gefitinib) after front-line platinum-based chemotherapy in advanced or metastatic non-small c…
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This Phase 1/2 clinical trial investigating a combination of gefitinib and sirolimus for recurrent or refractory stage IIIB/IV non-small cel…
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases [Phase 1]
A Phase 1 trial evaluating stereotactic radiosurgery with erlotinib for non-small cell lung cancer and brain metastases was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-22Clinical Trial Update: Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
This update notes that a Phase 1 trial evaluating neutron therapy for stage III non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-09Clinical Trial Update: A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. [Phase 2]
A Phase 2 trial in advanced non-small cell lung cancer evaluating new agents with and without docetaxel has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: Iressa/Docetaxel in Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial of Iressa (gefitinib) with docetaxel for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-23Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase III trial of Tariquidar with Paclitaxel/Carboplatin as first-line therapy in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 open-label study of a GARFT inhibitor in patients with metastatic non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy [Phase 2]
This update reports a Phase 2 trial evaluating the carboplatin, ixabepilone, and cetuximab combination in stage III or IV non-small cell lun…
-
CLINICAL_TRIALS withdrawal · 2012-02-08Clinical Trial Update: Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A Phase I/II clinical trial for patients with recurrent or refractory non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-10-10Clinical Trial Update: Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors [Phase 2]
A Phase 2 trial of zalutumumab in non-small cell lung cancer patients refractory to tyrosine kinase inhibitors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-09-09Clinical Trial Update: A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating CBT-1 in combination with Paclitaxel and Carboplatin for advanced, inoperable Non-Small Cell Lung Cancer was termin…
-
CLINICAL_TRIALS withdrawal · 2011-07-14Clinical Trial Update: Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer
A clinical trial evaluating the effects of radiation therapy on the body in patients with stage III non-small cell lung cancer has been with…
-
CLINICAL_TRIALS withdrawal · 2011-03-01Clinical Trial Update: Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
Expanded-access multicenter study of Lucanix (Belagenpumatucel-L) for non-small cell lung cancer is no longer available.